Ignite Creation Date:
2024-05-05 @ 4:41 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00293917
Status:
COMPLETED
Last Update Posted:
2008-02-13
First Post:
2006-02-16
Brief Title:
A Study to Assess the Long-Term Safety of Tacrolimus Cream in the Treatment of Psoriasis
Sponsor:
Astellas Pharma Inc
Organization:
Astellas Pharma Inc
Study Overview
Official Title:
A Phase 3 Long-Term Open Label Study to Evaluate the Safety of Twice Daily Tacrolimus Cream-B 01 in the Treatment of Psoriasis
Status:
COMPLETED
Status Verified Date:
2008-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A study to assess the long-term safety of tacrolimus cream in the treatment of psoriasis
Detailed Description:
A long-term open label non-comparative multi-center study to evaluate the safety of tacrolimus cream-B 01 in treating the signs and symptoms of psoriasis
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None